Stephens Inc’s Axogen AXGN Stock Holding History

Stephens Inc’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,609	Closed	-$289K	–	1148
2019 Q2	$289K	Buy	14,609 +2,500	+21%	+$53.5K	0.01%	934
2019 Q1	$255K	Buy	+12,109	New	+$221K	0.01%	970

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Stephens Inc's AXGN Position: Q3 2019 in Review

Stephens Inc sold out of Axogen (AXGN) in Q3 2019, closing a stake of 14,609 shares — an estimated $289K sold.

Stephens Inc first reported a position in AXGN in Q1 2019 and held it in 2 quarters. The position peaked at $289K in Q2 2019. 125 funds tracked by Wall St. Rank hold AXGN as of Q3 2019.

Stephens Inc reported no remaining Axogen position as of Q3 2019 after selling out during the quarter.
Stephens Inc sold 14,609 Axogen shares in Q3 2019, an estimated $289K.
Stephens Inc first reported a position in Axogen in Q1 2019 and held it in 2 quarters.
Stephens Inc's Axogen position peaked at $289K in Q2 2019.
125 funds tracked by Wall St. Rank held Axogen as of Q3 2019.

Based on Stephens Inc's 13F filing for Q3 2019, filed 18 Oct 2019.